Polatuzumab Vedotin-piiq
Ibrutinib Plus Bendamustine and Rituximab
JNCCN: How to Manage Cancer Care During COVID-19 Pandemic
National Cancer Institute: Lymphoma—Patient Version
Leukemia & Lymphoma Society
CancerCare